Emergency approval for the COVID-19 vaccine developed by drug company partners Pfizer and BioNTech, is under review by the U.S. Food and Drug Administration.
If the data from advanced vaccine trials is deemed safe by the U.S. authorities, approval for roll-out could come within weeks.
This comes as the number of American deaths from the coronavirus continues to surge.
From Washington, Nina-Maria Potts reports:
IN: “ It’s the…
OUT: SOC
DUR: 40 seconds